Evidence map›Paper›PMID 29200459›Full record

ArticleAmerican journal of pharmaceutical education2017

Competency, Programming, and Emerging Innovation in Graduate Education within Schools of Pharmacy: The Report of the 2016-2017 Research and Graduate Affairs Committee.

Samuel M Poloyac, Kirsten F Block, Jane E Cavanaugh, Linda P Dwoskin, Russell B Melchert, Ruth E Nemire, James M O'Donnell, Ronny Priefer, Daniel R Touchette

Open access · goldAbstract read
In one paragraph

Article in American journal of pharmaceutical education, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 19 citations in OpenAlex.

  1. The importance of rigor in pharmacy research: Challenges and solutions.Research in social & administrative pharmacy : RSAP · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Report of the 2018-2019 Research and Graduate Affairs Committee.American journal of pharmaceutical education · 2019
    Article
  6. Development of Guiding Principles for a New Era in Graduate Education.American journal of pharmaceutical education · 2019
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 8 institutions in 1 country.

Samuel M PoloyacUniversity of Pittsburgh School of Pharmacy, Pittsburgh, Pennsylvania.
Kirsten F BlockAmerican Association of Colleges of Pharmacy, Alexandria, Virginia.
Jane E CavanaughDuquesne University School of Pharmacy, Pittsburgh, Pennsylvania.
Linda P DwoskinUniversity of Kentucky College of Pharmacy, Lexington, Kentucky.
Russell B MelchertUniversity of Missouri-Kansas City School of Pharmacy, Kansas City, Missouri.
Ruth E NemireAmerican Association of Colleges of Pharmacy, Alexandria, Virginia.
James M O'DonnellUniversity at Buffalo, The State University of New York School of Pharmacy and Pharmaceutical Sciences, Buffalo, New York.
Ronny PrieferWestern New England University College of Pharmacy, Springfield, Massachussetts.
Daniel R TouchetteUniversity of Illinois at Chicago College of Pharmacy, Chicago, Illinois.
American Association of Colleges of Pharmacy · USDuquesne University · USUniversity at Buffalo, State University of New York · USUniversity of Illinois Chicago · USUniversity of Kentucky · USUniversity of Missouri–Kansas City · USUniversity of Pittsburgh · USWestern New England University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Graduate education in the pharmaceutical sciences is a cornerstone of research within pharmacy schools. Pharmaceutical scientists are critical contributors to addressing the challenges of new drug discovery, delivery, and optimal care in order to ensure improved therapeutic outcomes in populations of patients. The American Association of Colleges of Pharmacy (AACP) charged the 2016-2017 Research and Graduate Affairs Committee (RGAC) to define the competencies necessary for graduate education in the pharmaceutical sciences (Charge 1), recommend collaborative curricular development across schools of pharmacy (Charge 2), recommend AACP programing for graduate education (Charge 3), and provide guidance on emerging areas for innovation in graduate education (Charge 4). With respect to Charges 1 and 2, the RGAC committee developed six domains of core competencies for graduate education in the pharmaceutical sciences as well as recommendations for shared programming. For Charge 3, the committee made 3 specific programming recommendations that include AACP sponsored regional research symposia, a professional development forum at the AACP INterim Meeting, and the addition of a graduate research and education poster session at the AACP Annual Meeting. For Charge 4, the committee recommended that AACP develop a standing committee of graduate program deans and directors to provide guidance to member schools in support of graduate program representation at AACP meetings, develop skills for interprofessional teamwork and augment research through integration of Pharm.D., Ph.D., postdoctoral associates, resident, and fellow experiences. Two proposed policy statements by the committee are that AACP believes core competencies are essential components of graduate education and AACP supports the inclusion of research and graduate education focuses in its portfolio of meetings and programs.

Indexed as

Competency-Based EducationStudents, PharmacyClinical CompetenceCurriculumEducational MeasurementEducation, Pharmacy, GraduateHumansPharmacy ResearchSchools, PharmacyUnited StatesDoctor of PhilosophyGraduate EducationMaster’s DegreePharmaceutical SciencesPharmacyResearchResearch and Graduate Affairs Committee

Identifiers

PMID29200459
PMCPMC5701334
OpenAlexW2770192211

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.